NCT02830139View on ClinicalTrials.gov

Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

March 15, 2020

Study Completion Date

March 15, 2020

Conditions
Malignant Neoplasm of Colorectum
Interventions
PROCEDURE

Hyperthermic intraperitoneal chemotherapy (HIPEC)

Normal saline 3000ml-4000ml, Cisplatin 60mg/m2, 5-Fu 1500mg/m2, 43°C, 60min, During surgery and 7 days after surgery.

PROCEDURE

Radical colorectal resection

radical colorectal resection with lymphadenectomy

DRUG

Oxaliplatin , Capecitabine

XELOX postoperative chemotherapy Oxaliplatin 130mg/m2 d1, Capecitabine 1000mg/m2 d1-14.

DRUG

Normal saline , Cisplatin , 5-Fu

Trial Locations (1)

430021

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Wuhan University

OTHER

NCT02830139 - Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter